Nicotine dependence and comorbid psychiatric disorders: Examination of specific genetic variants in the CHRNA5-A3-B4 nicotinic receptor genes

Drug and Alcohol Dependence

Volumn 123, Issue SUPPL.1, 2012, Pages

  Chen, Li Shiun ^a   Xian, Hong ^b   Grucza, Richard A ^a   Saccone, Nancy L ^a   Wang, Jen C ^a   Johnson, Eric O ^c   Breslau, Naomi ^d   Hatsukami, Dorothy ^e   Bierut, Laura J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c RTI INTERNATIONAL   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Case control study; Comorbidity; Genetic epidemiology; Nicotine dependence; Nicotinic receptor genes; Pleiotropy

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; CANNABIS ADDICTION; CASE CONTROL STUDY; COMORBIDITY; CONDUCT DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DSM-IV; FEMALE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; NICOTINIC RECEPTOR GENE; PANIC; PLEIOTROPY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPATHY; RECEPTOR GENE; SOCIAL PHOBIA; TOBACCO DEPENDENCE;

ADULT; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PLEIOTROPY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; RECEPTORS, NICOTINIC; RISK FACTORS; TOBACCO USE DISORDER;

CANNABIS;

EID: 84862870071     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.01.014     Document Type: Article

References (47)

1. Agrawal A., Lynskey M.T., Pergadia M.L., Bucholz K.K., Heath A.C., Martin N.G., Madden P.A. Early cannabis use and DSM-IV nicotine dependence: a twin study. Addiction 2008, 103:1896-1904.
2. Amos C.I., Wu X., Broderick P., Gorlov I.P., Gu J., Eisen T., Dong Q., Zhang Q., Gu X., Vijayakrishnan J., Sullivan K., Matakidou A., Wang Y., Mills G., Doheny K., Tsai Y.Y., Chen W.V., Shete S., Spitz M.R., Houlston R.S. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 2008, 40:616-622.
3. Bierut L.J., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O.F., Swan G.E., Rutter J., Bertelsen S., Fox L., Fugman D., Goate A.M., Hinrichs A.L., Konvicka K., Martin N.G., Montgomery G.W., Saccone N.L., Saccone S.F., Wang J.C., Chase G.A., Rice J.P., Ballinger D.G. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 2007, 16:24-35.
4. Bierut L.J., Stitzel J.A., Wang J.C., Hinrichs A.L., Grucza R.A., Xuei X., Saccone N.L., Saccone S.F., Bertelsen S., Fox L., Horton W.J., Morgan S.D., Breslau N., Budde J., Cloninger C.R., Dick D.M., Foroud T., Hatsukami D., Hesselbrock V., Johnson E.O., Kramer J., Kuperman S., Madden P.A.F., Mayo K., Nurnberger J.J., Pomerleau O., Porjesz B., Reyes O., Schuckit M., Swan G., Tischfield J.A., Edenberg H.J., Rice J.P., Goate A.M. Nicotine dependence and the a5-a3-b4 nicotinic receptor gene cluster: variants in the nicotinic receptors alter the risk for nicotine dependence. Am. J. Psychiatry 2008, 1163-1171.
5. Bondy S.J., Victor J.C., Diemert L.M. Origin and use of the 100 cigarette criterion in tobacco surveys. Tob. Control 2009, 18:317-323.
6. Breslau N. Psychiatric comorbidity of smoking and nicotine dependence. Behav. Genet. 1995, 25:95-101.
7. Breslau N., Novak S.P., Kessler R.C. Daily smoking and the subsequent onset of psychiatric disorders. Psychol. Med. 2004, 34:323-333.
8. Breslau N., Novak S.P., Kessler R.C. Psychiatric disorders and stages of smoking. Biol. Psychiatry 2004, 55:69-76.
9. Bucholz K.K., Cadoret R., Cloninger C.R., Dinwiddie S.H., Hesselbrock V.M., Nurnberger J.I., Reich T., Schmidt I., Schuckit M.A. A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J. Stud. Alcohol 1994, 55:149-158.
10. CDC Smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 2000-2004. MMWR 2008, 57:1226-1228.
11. CDC Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR 2009, 58:1227-1232.
12. Chanock S.J., Hunter D.J. Genomics: when the smoke clears. Nature 2008, 452:537-538.
13. Cohen L. Statistical Power Analysis for the Behavioral Sciences 1988, Erlbaum Associates, Hillsdale, NJ.
14. Dierker L., Donny E. The role of psychiatric disorders in the relationship between cigarette smoking and DSM-IV nicotine dependence among young adults. Nicotine Tob. Res. 2008, 10:439-446.
15. Falk D.E., Yi H.Y., Hiller-Sturmhofel S. An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Res. Health 2006, 29:162-171.
16. Fu Q., Heath A.C., Bucholz K.K., Lyons M.J., Tsuang M.T., True W.R., Eisen S.A. Common genetic risk of major depression and nicotine dependence: the contribution of antisocial traits in a United States veteran male twin cohort. Twin Res. Hum. Genet. 2007, 10:470-478.
17. Gauderman W., Morrison J. QUANTO 1.1: A Computer Program for Power and Sample Size Calculations for Genetic-epidemiology Studies 2006, Univ. of Southern California.
18. Golub A., Johnson B.D. Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. Am. J. Public Health 2001, 91:225-232.
19. Goodwin R.D., Zvolensky M.J., Keyes K.M. Nicotine dependence and mental disorders among adults in the USA: evaluating the role of the mode of administration. Psychol. Med. 2008, 38:1277-1286.
20. Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., Dawson D.A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2004, 61:1107-1115.
21. Griesler P.C., Hu M.C., Schaffran C., Kandel D.B. Comorbidity of psychiatric disorders and nicotine dependence among adolescents: findings from a prospective, longitudinal study. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47:1340-1350.
22. Hasin D., Fenton M.C., Skodol A., Krueger R., Keyes K., Geier T., Greenstein E., Blanco C., Grant B. Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders. Arch. Gen. Psychiatry 2011, 68:1158-1167.
23. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br. J. Addict. 1991, 86:1119-1127.
24. Hesselbrock M., Easton C., Bucholz K.K., Schuckit M., Hesselbrock V. A validity study of the SSAGA - a comparison with the SCAN. Addiction 1999, 94:1361-1370.
25. Hettema J.M., Corey L.A., Kendler K.S. A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins. Drug Alcohol Depend. 1999, 57:69-78.
26. Hung R.J., McKay J.D., Gaborieau V., Boffetta P., Hashibe M., Zaridze D., Mukeria A., Szeszenia-Dabrowska N., Lissowska J., Rudnai P., Fabianova E., Mates D., Bencko V., Foretova L., Janout V., Chen C., Goodman G., Field J.K., Liloglou T., Xinarianos G., Cassidy A., McLaughlin J., Liu G., Narod S., Krokan H.E., Skorpen F., Elvestad M.B., Hveem K., Vatten L., Linseisen J., Clavel-Chapelon F., Vineis P., Bueno-de-Mesquita H.B., Lund E., Martinez C., Bingham S., Rasmuson T., Hainaut P., Riboli E., Ahrens W., Benhamou S., Lagiou P., Trichopoulos D., Holcatova I., Merletti F., Kjaerheim K., Agudo A., Macfarlane G., Talamini R., Simonato L., Lowry R., Conway D.I., Znaor A., Healy C., Zelenika D., Boland A., Delepine M., Foglio M., Lechner D., Matsuda F., Blanche H., Gut I., Heath S., Lathrop M., Brennan P. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008, 452:633-637. [see comment].
27. Hunter D.J. Gene-environment interactions in human diseases. Nat. Rev. Genet. 2005, 6:287-298.
28. John U., Meyer C., Rumpf H.J., Hapke U. Probabilities of alcohol high-risk drinking, abuse or dependence estimated on grounds of tobacco smoking and nicotine dependence. Addiction 2003, 98:805-814.
29. Kendler K.S., Neale M.C., MacLean C.J., Heath A.C., Eaves L.J., Kessler R.C. Smoking and major depression. A causal analysis. Arch. Gen. Psychiatry 1993, 50:36-43.
30. Klungsoyr O., Nygard J.F., Sorensen T., Sandanger I. Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study. Am. J. Epidemiol. 2006, 163:421-432.
31. Liu J.Z., Tozzi F., Waterworth D.M., Pillai S.G., Muglia P., Middleton L., Berrettini W., Knouff C.W., Yuan X., Waeber G., Vollenweider P., Preisig M., Wareham N.J., Zhao J.H., Loos R.J., Barroso I., Khaw K.T., Grundy S., Barter P., Mahley R., Kesaniemi A., McPherson R., Vincent J.B., Strauss J., Kennedy J.L., Farmer A., McGuffin P., Day R., Matthews K., Bakke P., Gulsvik A., Lucae S., Ising M., Brueckl T., Horstmann S., Wichmann H.E., Rawal R., Dahmen N., Lamina C., Polasek O., Zgaga L., Huffman J., Campbell S., Kooner J., Chambers J.C., Burnett M.S., Devaney J.M., Pichard A.D., Kent K.M., Satler L., Lindsay J.M., Waksman R., Epstein S., Wilson J.F., Wild S.H., Campbell H., Vitart V., Reilly M.P., Li M., Qu L., Wilensky R., Matthai W., Hakonarson H.H., Rader D.J., Franke A., Wittig M., Schafer A., Uda M., Terracciano A., Xiao X., Busonero F., Scheet P., Schlessinger D., St Clair D., Rujescu D., Abecasis G.R., Grabe H.J., Teumer A., Volzke H., Petersmann A., John U., Rudan I., Hayward C., Wright A.F., Kolcic I., Wright B.J., Thompson J.R., Balmforth A.J., Hall A.S., Samani N.J., Anderson C.A., Ahmad T., Mathew C.G., Parkes M., Satsangi J., Caulfield M., Munroe P.B., Farrall M., Dominiczak A., Worthington J., Thomson W., Eyre S., Barton A., Mooser V., Francks C., Marchini J. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat. Genet. 2010, 42:436-440.
32. Lyons M., Hitsman B., Xian H., Panizzon M.S., Jerskey B.A., Santangelo S., Grant M.D., Rende R., Eisen S., Eaves L., Tsuang M.T. A twin study of smoking, nicotine dependence, and major depression in men. Nicotine Tob. Res. 2008, 10:97-108.
33. Pasco J.A., Williams L.J., Jacka F.N., Ng F., Henry M.J., Nicholson G.C., Kotowicz M.A., Berk M. Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br. J. Psychiatry 2008, 193:322-326.
34. Pedersen W., von Soest T. Smoking, nicotine dependence and mental health among young adults: a 13-year population-based longitudinal study. Addiction 2009, 104:129-137.
35. Robins L.N., Wing J., Wittchen H.U., Helzer J.E., Babor T.F., Burke J., Farmer A., Jablenski A., Pickens R., Regier D.A. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch. Gen. Psychiatry 1988, 45:1069-1077.
36. Saccone N.L., Culverhouse R.C., Schwantes-An T.H., Cannon D.S., Chen X., Cichon S., Giegling I., Han S., Han Y., Keskitalo-Vuokko K., Kong X., Landi M.T., Ma J.Z., Short S.E., Stephens S.H., Stevens V.L., Sun L., Wang Y., Wenzlaff A.S., Aggen S.H., Breslau N., Broderick P., Chatterjee N., Chen J., Heath A.C., Heliovaara M., Hoft N.R., Hunter D.J., Jensen M.K., Martin N.G., Montgomery G.W., Niu T., Payne T.J., Peltonen L., Pergadia M.L., Rice J.P., Sherva R., Spitz M.R., Sun J., Wang J.C., Weiss R.B., Wheeler W., Witt S.H., Yang B.Z., Caporaso N.E., Ehringer M.A., Eisen T., Gapstur S.M., Gelernter J., Houlston R., Kaprio J., Kendler K.S., Kraft P., Leppert M.F., Li M.D., Madden P.A., Nothen M.M., Pillai S., Rietschel M., Rujescu D., Schwartz A., Amos C.I., Bierut L.J. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet. 2010, 6.
37. Saccone N.L., Saccone S.F., Hinrichs A.L., Stitzel J.A., Duan W., Pergadia M.L., Agrawal A., Breslau N., Grucza R.A., Hatsukami D., Johnson E.O., Madden P.A., Swan G.E., Wang J.C., Goate A.M., Rice J.P., Bierut L.J. Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2009, 150B:453-466.
38. Saccone S.F., Hinrichs A.L., Saccone N.L., Chase G.A., Konvicka K., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O., Swan G.E., Goate A.M., Rutter J., Bertelsen S., Fox L., Fugman D., Martin N.G., Montgomery G.W., Wang J.C., Ballinger D.G., Rice J.P., Bierut L.J. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet. 2007, 16:36-49.
39. Sihvola E., Rose R.J., Dick D.M., Pulkkinen L., Marttunen M., Kaprio J. Early-onset depressive disorders predict the use of addictive substances in adolescence: a prospective study of adolescent Finnish twins. Addiction 2008, 103:2045-2053.
40. Swendsen J., Conway K.P., Degenhardt L., Glantz M., Jin R., Merikangas K.R., Sampson N., Kessler R.C. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2010, 105:1117-1128.
41. TAG Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 2010, 42:441-447.
42. Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K.P., Manolescu A., Thorleifsson G., Stefansson H., Ingason A., Stacey S.N., Bergthorsson J.T., Thorlacius S., Gudmundsson J., Jonsson T., Jakobsdottir M., Saemundsdottir J., Olafsdottir O., Gudmundsson L.J., Bjornsdottir G., Kristjansson K., Skuladottir H., Isaksson H.J., Gudbjartsson T., Jones G.T., Mueller T., Gottsater A., Flex A., Aben K.K.H., de Vegt F., Mulders P.F.A., Isla D., Vidal M.J., Asin L., Saez B., Murillo L., Blondal T., Kolbeinsson H., Stefansson J.G., Hansdottir I., Runarsdottir V., Pola R., Lindblad B., van Rij A.M., Dieplinger B., Haltmayer M., Mayordomo J.I., Kiemeney L.A., Matthiasson S.E., Oskarsson H., Tyrfingsson T., Gudbjartsson D.F., Gulcher J.R., Jonsson S., Thorsteinsdottir U., Kong A., Stefansson K. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008, 452:638-642.
43. Thorgeirsson T.E., Gudbjartsson D.F., Surakka I., Vink J.M., Amin N., Geller F., Sulem P., Rafnar T., Esko T., Walter S., Gieger C., Rawal R., Mangino M., Prokopenko I., Magi R., Keskitalo K., Gudjonsdottir I.H., Gretarsdottir S., Stefansson H., Thompson J.R., Aulchenko Y.S., Nelis M., Aben K.K., den Heijer M., Dirksen A., Ashraf H., Soranzo N., Valdes A.M., Steves C., Uitterlinden A.G., Hofman A., Tonjes A., Kovacs P., Hottenga J.J., Willemsen G., Vogelzangs N., Doring A., Dahmen N., Nitz B., Pergadia M.L., Saez B., De Diego V., Lezcano V., Garcia-Prats M.D., Ripatti S., Perola M., Kettunen J., Hartikainen A.L., Pouta A., Laitinen J., Isohanni M., Huei-Yi S., Allen M., Krestyaninova M., Hall A.S., Jones G.T., van Rij A.M., Mueller T., Dieplinger B., Haltmayer M., Jonsson S., Matthiasson S.E., Oskarsson H., Tyrfingsson T., Kiemeney L.A., Mayordomo J.I., Lindholt J.S., Pedersen J.H., Franklin W.A., Wolf H., Montgomery G.W., Heath A.C., Martin N.G., Madden P.A., Giegling I., Rujescu D., Jarvelin M.R., Salomaa V., Stumvoll M., Spector T.D., Wichmann H.E., Metspalu A., Samani N.J., Penninx B.W., Oostra B.A., Boomsma D.I., Tiemeier H., van Duijn C.M., Kaprio J., Gulcher J.R., McCarthy M.I., Peltonen L., Thorsteinsdottir U., Stefansson K. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet. 2010, 42:448-453.
44. True W.R., Xian H., Scherrer J.F., Madden P.A., Bucholz K.K., Heath A.C., Eisen S.A., Lyons M.J., Goldberg J., Tsuang M. Common genetic vulnerability for nicotine and alcohol dependence in men. Arch. Gen. Psychiatry 1999, 56:655-661.
45. Wang J.C., Cruchaga C., Saccone N.L., Bertelsen S., Liu P., Budde J.P., Duan W., Fox L., Grucza R.A., Kern J., Mayo K., Reyes O., Rice J., Saccone S.F., Spiegel N., Steinbach J.H., Stitzel J.A., Anderson M.W., You M., Stevens V.L., Bierut L.J., Goate A.M. Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum. Mol. Genet. 2009, 18:3125-3135.
46. Whitfield J.B., Zhu G., Nestler J.E., Heath A.C., Martin N.G. Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. Clin. Chem. 2002, 48:1426-1431.
47. Young S.E., Rhee S.H., Stallings M.C., Corley R.P., Hewitt J.K. Genetic and environmental vulnerabilities underlying adolescent substance use and problem use: general or specific?. Behav. Genet. 2006, 36:603-615.